反応式
Br.N1CCC[C@H]1C([N:6]1[CH2:13][CH2:12][CH2:11][C@H:7]1[C:8]([OH:10])=[O:9])=O.[N+](C1C=CC([O:26][C:27](=[O:44])[C@H:28]([C@H:40]([CH2:42][CH3:43])[CH3:41])[NH:29][C:30]([O:32][CH2:33][C:34]2[CH:39]=[CH:38][CH:37]=[CH:36][CH:35]=2)=[O:31])=CC=1)([O-])=O.ON1C2C=CC=CC=2N=N1.CN(CCCN)C>CN(C)C=O.C(N(CC)CC)C>[CH2:33]([O:32][C:30]([NH:29][C@H:28]([C:27]([N:6]1[CH2:13][CH2:12][CH2:11][C@H:7]1[C:8]([OH:10])=[O:9])=[O:44])[C@H:40]([CH2:42][CH3:43])[CH3:41])=[O:31])[C:34]1[CH:35]=[CH:36][CH:37]=[CH:38][CH:39]=1.[NH:29]1[CH2:43][CH2:42][CH2:40][C@H:28]1[C:27]([OH:26])=[O:44]参加物
反応物 4
生成物 1
試薬・触媒・溶媒 2
実験手順
Prolyl-proline hydrobromide (4.24 g) is dissolved in a mixture of dimethylformamide (40 ml) and triethylamine (2.8 ml). Benzyloxycarbonyl-isoleucine p-nitrophenyl ester (9.27 g) and 1-hydroxybenzotriazole (3 g) are added and the mixture is stored at room temperature for 16 hours. Dimethylaminopropylamine (1 ml) is added and after 2 hours the solvent is removed in vacuo. The residue is dissolved in ethyl acetate (200 ml) and washed sequentially with 0.1 N hydrochloric acid, and water. The organic phase is dried over magnesium sulfate and concentrated to dryness in vacuo to yield 13.8 g solid. This material is applied to a silica gel column (300 g) in ethyl acetate and eluted with the same solvent. The fractions containing the desired above-titled tripeptide are pooled and concentrated to dryness.
後処理
- customis removed in vacuo
- dissolutionThe residue is dissolved in ethyl acetate (200 ml)
- washwashed sequentially with 0.1 N hydrochloric acid, and water
- dry with materialThe organic phase is dried over magnesium sulfate
- concentrationconcentrated to dryness in vacuo
出典と根拠
- ORDレコード
- ord-8f539f9468b14564a0c78dd7fc405e85
- 出典データセット
- uspto-grants-1976_08
- 特許番号
- US03973006
関連ノート
読み込み中…